Millard, N., Becher, O., Modak, S., Haque, S., Spasojevic, I., Trippett, T., … Dunkel, I. (2016). A PHASE I STUDY OF SINGLE-AGENT PERIFOSINE FOR RECURRENT/REFRACTORY PEDIATRIC CNS AND SOLID TUMORS. NEURO-ONCOLOGY, 18, 25–25.

Millard, Nathan, Oren Becher, Shakeel Modak, Sofia Haque, Ivan Spasojevic, Tanya Trippett, Stephen Gilheeney, et al. “A PHASE I STUDY OF SINGLE-AGENT PERIFOSINE FOR RECURRENT/REFRACTORY PEDIATRIC CNS AND SOLID TUMORS.” NEURO-ONCOLOGY 18 (June 1, 2016): 25–25.

Millard N, Becher O, Modak S, Haque S, Spasojevic I, Trippett T, et al. A PHASE I STUDY OF SINGLE-AGENT PERIFOSINE FOR RECURRENT/REFRACTORY PEDIATRIC CNS AND SOLID TUMORS. NEURO-ONCOLOGY. 2016 Jun 1;18:25–25.

Millard, Nathan, et al. “A PHASE I STUDY OF SINGLE-AGENT PERIFOSINE FOR RECURRENT/REFRACTORY PEDIATRIC CNS AND SOLID TUMORS.” NEURO-ONCOLOGY, vol. 18, OXFORD UNIV PRESS INC, June 2016, pp. 25–25.

Millard N, Becher O, Modak S, Haque S, Spasojevic I, Trippett T, Gilheeney S, Khakoo Y, Lyden D, De Braganca K, Kolesar J, Huse J, Kramer K, Dunkel I. A PHASE I STUDY OF SINGLE-AGENT PERIFOSINE FOR RECURRENT/REFRACTORY PEDIATRIC CNS AND SOLID TUMORS. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2016 Jun 1;18:25–25.